273 related articles for article (PubMed ID: 33355651)
1. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
3. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
4. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
5. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
Xu S; Zhou J; Liu K; Chen Z; He Z
Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
[TBL] [Abstract][Full Text] [Related]
6. Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung.
Yang HC; Kim HR; Jheon S; Kim K; Cho S; Ahn S; Lee HY; Chung JH; Chung KY; Bae MK; Park SY; Kim DK; Choi SH; Zo JI; Kim MS; Lee JM; Kim J; Shim YM; Na KJ; Yun JS; Park JY
Ann Surg Oncol; 2015 Nov; 22(12):4089-97. PubMed ID: 25783676
[TBL] [Abstract][Full Text] [Related]
7. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
[TBL] [Abstract][Full Text] [Related]
8. Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.
Aramini B; Casali C; Stefani A; Bettelli S; Wagner S; Sangale Z; Hughes E; Lanchbury JS; Maiorana A; Morandi U
Lung Cancer; 2016 Nov; 101():82-87. PubMed ID: 27794412
[TBL] [Abstract][Full Text] [Related]
9. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
11. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
12. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma.
Lee JS; Kim EK; Kim KA; Shim HS
Cancer Res Treat; 2024 Jan; 56(1):104-114. PubMed ID: 37499696
[TBL] [Abstract][Full Text] [Related]
16. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
[TBL] [Abstract][Full Text] [Related]
17. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.
Zhou J; Sanchez-Vega F; Caso R; Tan KS; Brandt WS; Jones GD; Yan S; Adusumilli PS; Bott M; Huang J; Isbell JM; Sihag S; Molena D; Rusch VW; Chatila WK; Rekhtman N; Yang F; Ladanyi M; Solit DB; Berger MF; Schultz N; Jones DR
Clin Cancer Res; 2019 Dec; 25(24):7475-7484. PubMed ID: 31455678
[TBL] [Abstract][Full Text] [Related]
19. Eight-gene signature predicts recurrence in lung adenocarcinoma.
Zhang Y; Fan Q; Guo Y; Zhu K
Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318
[TBL] [Abstract][Full Text] [Related]
20. A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.
Carr SR; Wang H; Hudlikar R; Lu X; Zhang MR; Hoang CD; Yan F; Schrump DS
J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1554-1564. PubMed ID: 37608989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
